Jump to content

User:Cmcheng28/sandbox

From Wikipedia, the free encyclopedia

Deoxycytidine kinase (dCK) predominantly phosphorylates deoxycytidine (dC) and converts dC into deoxycytidine monophosphate. dCK catalyzes one of the initial steps in the nucleotide salvage pathway[1] and has the potential to phosphorylate other preformed nucleosides, specifically deoxyadenosine (dA) and deoxyguanosine (dG), and convert them into their monophosphate forms.[2] [3][4][5][6]

Therapeutics and Prodrugs

[edit]

gemcitabine [7]

References

[edit]
  1. ^ Nathanson, David A.; Armijo, Amanda L.; Tom, Michelle; Li, Zheng; Dimitrova, Elizabeth; Austin, Wayne R.; Nomme, Julian; Campbell, Dean O.; Ta, Lisa (2014-03-10). "Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication". The Journal of Experimental Medicine. 211 (3): 473–486. doi:10.1084/jem.20131738. ISSN 0022-1007. PMC 3949575. PMID 24567448.
  2. ^ Sabini, Elisabetta; Ort, Stephan; Monnerjahn, Christian; Konrad, Manfred; Lavie, Arnon (2003-07-01). "Structure of human dCK suggests strategies to improve anticancer and antiviral therapy". Nature Structural & Molecular Biology. 10 (7): 513–519. doi:10.1038/nsb942. ISSN 1072-8368.
  3. ^ Hazra, Saugata; Szewczak, Andrzej; Ort, Stephan; Konrad, Manfred; Lavie, Arnon (2011-04-12). "Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release". Biochemistry. 50 (14): 2870–2880. doi:10.1021/bi2001032. ISSN 1520-4995. PMC 3071448. PMID 21351740.
  4. ^ van der Wilt, C.L; Kroep, J.R; Loves, W.J.P; Rots, M.G; Groeningen, C.J Van; Kaspers, G.J; Peters, G.J. "Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver". European Journal of Cancer. 39 (5): 691–697. doi:10.1016/s0959-8049(02)00813-4.
  5. ^ Arnér, Elias S. J.; Eriksson, Staffan (1995-01-01). "Mammalian deoxyribonucleoside kinases". Pharmacology & Therapeutics. 67 (2): 155–186. doi:10.1016/0163-7258(95)00015-9.
  6. ^ Yamada, Yasukazu; Goto, Haruko; Ogasawara, Nobuaki (1983-11-22). "Purine nucleoside kinases in human T- and B-lymphoblasts". Biochimica et Biophysica Acta (BBA) - General Subjects. 761 (1): 34–40. doi:10.1016/0304-4165(83)90359-8.
  7. ^ "FDA Approval for Gemcitabine Hydrochloride". National Cancer Institute. Retrieved 2016-11-01.